Top

Current Cardiology Reports

Published in:

01-11-2018 | Echocardiography (JM Gardin and AH Waller, Section Editors)

What Is the Clinical Utility of Intravascular Ultrasound?

Authors: Eisha Wali, Sandeep Nathan

Published in: Current Cardiology Reports | Issue 11/2018

Abstract

Purpose of Review

This article reviews the contemporary evidence base for use of coronary intravascular ultrasound (IVUS).

Recent Findings

Recent studies have strongly associated IVUS guidance during percutaneous coronary angioplasty (PCI) with lower major adverse cardiac events (MACE), stent thrombosis, and in selected groups, mortality. The PROSPECT study found in acute coronary syndromes patients, IVUS-determined minimal luminal area ≤ 4.0 mm² and the presence of thin-cap fibroatheromas were independent predictors of future MACE in non-culprit lesions. A sub-analysis of the ADAPT-DES trial demonstrated significant reductions in stent thrombosis, myocardial infarction, and composite MACE in patients with IVUS-guided PCI versus angiography alone. In patients with cardiac allograft vasculopathy, IVUS measurements of intimal thickening and attenuated-signal plaque are associated with increased mortality.

Summary

IVUS has become a ubiquitous and versatile adjunct to conventional angiography. It is a powerful tool for identification and assessment of atherosclerotic disease, guidance of percutaneous coronary intervention, and detection of cardiac allograft vasculopathy.

Riley RF, Don CW, Powell W, Maynard C, Dean LS. Trends in coronary revascularization in the United States from 2001 to 2009: recent declines in percutaneous coronary intervention volumes. Circ Cardiovasc Qual Outcomes. 2011;4:193–7. https://doi.org/10.1161/CIRCOUTCOMES.110.958744.CrossRefPubMedPubMedCentral

Retzer EM, Jagadeesan V, Nathan S. Intravascular ultrasound: applications and limitations. In: Lang R, Goldstein SA, Kronzon I, Khanderia BK, Mor-Avi V, editors. ASE’s Compr. Echocardiogr. 2nd ed., 2015.

Jagadeesan V, Retzer EM, Nathan S. Intravascular ultrasound: instrumentation and technique. In: Lang RM, Goldstein SA, Kronzon I, Khanderia BK, Mor-Avi V, editors. ASE’s Compr. Echocardiogr. 2nd ed., Elsevier; 2015, p. 75–8.

ACIST kodama intravascular ultrasound catheter n.d. https://www.accessdata.fda.gov/cdrh_docs/pdf17/K173063.pdf (accessed July 23, 2018).

Topol EJ, Nissen SE. Our preoccupation with coronary luminology: the dissociation between clinical and angiographic findings in ischemic heart disease. Circulation. 1995;92:2333–42. https://doi.org/10.1161/01.CIR.92.8.2333.CrossRefPubMed

Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371–5. https://doi.org/10.1056/NEJM198705283162204.CrossRefPubMed

Matthews SD, Frishman WH. A review of the clinical utility of intravascular ultrasound and optical coherence tomography in the assessment and treatment of coronary artery disease. Cardiol Rev. 2017;25:68–76. https://doi.org/10.1097/CRD.0000000000000128.CrossRefPubMed

Yamagishi M, Miyatake K, Tamai J, Nakatani S, Koyama J, Nissen SE. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. J Am Coll Cardiol. 1994;23:352–7. https://doi.org/10.1016/0735-1097(94)90419-7.CrossRefPubMed

St Goar FG, Pinto FJ, Alderman EL, Valantine HA, Schroeder JS, Gao SZ, et al. Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of “angiographically silent” intimal thickening. Circulation. 1992;85:979–87.CrossRefPubMed

10.

•• Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226–35. https://doi.org/10.1056/NEJMoa1002358 A prospective trial which demonstrated that minimal luminal area of 4.0mm or less and presence of thin-cap fibroatheromas on IVUS evaluation were independent predictors of subsequent MACE in nonculprit lesions. CrossRefPubMed

11.

Koo B-K, Yang H-M, Doh J-H, Choe H, Lee S-Y, Yoon C-H, et al. Optimal intravascular ultrasound criteria and their accuracy for defining the functional significance of intermediate coronary stenoses of different locations. JACC Cardiovasc Interv. 2011;4:803–11. https://doi.org/10.1016/J.JCIN.2011.03.013.CrossRefPubMed

12.

Park S-J, Ahn J-M, Kang S-J, Yoon S-H, Koo B-K, Lee J-Y, et al. Intravascular ultrasound-derived minimal lumen area criteria for functionally significant left main coronary artery stenosis. JACC Cardiovasc Interv. 2014;7:868–74. https://doi.org/10.1016/j.jcin.2014.02.015.CrossRefPubMed

13.

Kang S-J, Ahn J-M, Song H, Kim W-J, Lee J-Y, Park D-W, et al. Usefulness of minimal luminal coronary area determined by intravascular ultrasound to predict functional significance in stable and unstable angina pectoris. Am J Cardiol. 2012;109:947–53. https://doi.org/10.1016/j.amjcard.2011.11.024.CrossRefPubMed

14.

McDaniel MC, Eshtehardi P, Sawaya FJ, Douglas JS, Samady H. Contemporary clinical applications of coronary intravascular ultrasound. JACC Cardiovasc Interv. 2011;4:1155–67. https://doi.org/10.1016/j.jcin.2011.07.013.CrossRefPubMed

15.

• Ben-Dor I, Mahmoudi M, Deksissa T, Bui AB, Gaglia MA, Gonzalez MA, et al. Correlation between fractional flow reserve and intravascular ultrasound lumen area in intermediate coronary artery stenosis. Cardiovasc Revascularization Med. 2011;12:e41. https://doi.org/10.1016/j.carrev.2011.04.353 A comparison of IVUS-derived vessel cross-sectional areas with commonly utilized FFR threshold measurements for the determination of physiologic significance in intermediate coronary stenoses. CrossRef

16.

Ma T, Zhou B, Hsiai TK, Shung KK. A review of intravascular ultrasound-based multimodal intravascular imaging: the synergistic approach to characterizing vulnerable plaques. Ultrason Imaging. 2016;38:314–31. https://doi.org/10.1177/0161734615604829.CrossRefPubMed

17.

Calvert PA, Obaid DR, O’Sullivan M, Shapiro LM, McNab D, Densem CG, et al. Association between IVUS findings and adverse outcomes in patients with coronary artery disease: The VIVA (VH-IVUS in vulnerable atherosclerosis) study. JACC Cardiovasc Imaging. 2011;4:894–901. https://doi.org/10.1016/J.JCMG.2011.05.005.CrossRefPubMed

18.

Cheng JM, Garcia-Garcia HM, de Boer SPM, Kardys I, Heo JH, Akkerhuis KM, et al. In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. Eur Heart J. 2014;35:639–47. https://doi.org/10.1093/eurheartj/eht484.CrossRefPubMed

19.

Van Herck J, De Meyer G, Ennekens G, Van Herck P, Herman A, Vrints C. Validation of in vivo plaque characterisation by virtual histology in a rabbit model of atherosclerosis. EuroIntervention. 2009;5:149–56.CrossRefPubMed

20.

Brown AJ, Obaid DR, Costopoulos C, Parker RA, Calvert PA, Teng Z, et al. Direct comparison of virtual-histology intravascular ultrasound and optical coherence tomography imaging for identification of thin-cap fibroatheroma. Circ Cardiovasc Imaging. 2015;8:e003487. https://doi.org/10.1161/CIRCIMAGING.115.003487.CrossRefPubMedPubMedCentral

21.

Moreno PR. The high-risk thin-cap fibroatheroma: a new kid on the block. Circ Cardiovasc Interv. 2009;2:500–2. https://doi.org/10.1161/CIRCINTERVENTIONS.109.922146.CrossRefPubMed

22.

•• Witzenbichler B, Maehara A, Weisz G, Neumann FJ, Rinaldi MJ, Metzger DC, et al. Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study. Circulation. 2014;129:463–70. https://doi.org/10.1161/CIRCULATIONAHA.113.003942 A prespecified subanalysis of a multicenter prospective trial which demonstrated a significant reduction in stent thrombosis, myocardial infarction, and composite MACE in patients with IVUS-guided PCI versus angiography alone. CrossRefPubMed

23.

Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–16. https://doi.org/10.1056/NEJMoa070829.CrossRefPubMed

24.

Nishigaki K, Yamazaki T, Kitabatake A, Yamaguchi T, Kanmatsuse K, Kodama I, et al. Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease a randomized, comparative, multicenter study 2008.

25.

• Zhang Y-J, Pang S, Chen X-Y, Bourantas CV, Pan D-R, Dong S-J, et al. Comparison of intravascular ultrasound guided versus angiography guided drug eluting stent implantation: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2015;15:153. https://doi.org/10.1186/s12872-015-0144-8 A systematic review and meta-analysis of patients receiving DES with or without IVUS guidance. CrossRefPubMedPubMedCentral

26.

Klersy C, Ferlini M, Raisaro A, Scotti V, Balduini A, Curti M, et al. Use of IVUS guided coronary stenting with drug eluting stent: a systematic review and meta-analysis of randomized controlled clinical trials and high quality observational studies. Int J Cardiol. 2013;170:54–63.CrossRefPubMed

27.

• Ahn JM, Kang SJ, Yoon SH, Park HW, Kang SM, Lee JY, et al. Meta-analysis of outcomes after intravascular ultrasound-guided versus angiography-guided drug-eluting stent implantation in 26,503 patients enrolled in three randomized trials and 14 observational studies. Am J Cardiol. 2014;113:1338–47. https://doi.org/10.1016/j.amjcard.2013.12.043 A meta-analysis assessing outcomes after IVUS-guided versus angiographically-guided DES placement. CrossRefPubMed

28.

Elgendy IY, Mahmoud AN, Elgendy AY, Bavry AA. Outcomes with intravascular ultrasound-guided stent implantation. Circ Cardiovasc Interv. 2016;9:e003700. https://doi.org/10.1161/CIRCINTERVENTIONS.116.003700.CrossRefPubMed

29.

Jang J-S, Song Y-J, Kang W, Jin H-Y, Seo J-S, Yang T-H, et al. Intravascular ultrasound-guided implantation of drug-eluting stents to improve outcome: a meta-analysis. JACC Cardiovasc Interv. 2014;7:233–43. https://doi.org/10.1016/j.jcin.2013.09.013.CrossRefPubMed

30.

Shin D-H, Hong S-J, Mintz GS, Kim J-S, Kim B-K, Ko Y-G, et al. Effects of intravascular ultrasound–guided versus angiography-guided new-generation drug-eluting stent implantation. JACC Cardiovasc Interv. 2016;9:2232–9. https://doi.org/10.1016/j.jcin.2016.07.021.CrossRefPubMed

31.

Hong SJ, Kim BK, Shin DH, Nam CM, Kim JS, Ko YG, et al. Effect of intravascular ultrasound-guided vs angiography- guided everolimus-eluting stent implantation: the IVUS-XPL randomized clinical trial. JAMA - J Am Med Assoc. 2015;314:2155–63. https://doi.org/10.1001/jama.2015.15454.CrossRef

32.

Park S-J, Kim Y-H, Park D-W, Lee S-W, Kim W-J, Suh J, et al. Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis. Circ Cardiovasc Interv. 2009;2:167–77. https://doi.org/10.1161/CIRCINTERVENTIONS.108.799494.CrossRefPubMed

33.

Wang Y, Mintz GS, Gu Z, Qi Y, Wang Y, Liu M, et al. Meta-analysis and systematic review of intravascular ultrasound versus angiography-guided drug eluting stent implantation in left main coronary disease in 4592 patients. BMC Cardiovasc Disord. 2018;18:115. https://doi.org/10.1186/s12872-018-0843-z.CrossRefPubMedPubMedCentral

34.

• Kang S-J, Ahn J-M, Song H, Kim W-J, Lee J-Y, Park D-W, et al. Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease. Circ Cardiovasc Interv. 2011;4:562–9. https://doi.org/10.1161/CIRCINTERVENTIONS.111.964643 A study assessing optimal IVUS stent area to predict in-stent restenosis for a DES in the LMCA. CrossRefPubMed

35.

Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, et al. ACCF/AHA/SCAI practice guideline for percutaneous coronary intervention: executive summary a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions 2011;124, 2574, 2609 doi:https://doi.org/10.1161/CIR.0b013e31823a5596.

36.

Sarno G, Lagerqvist B, Nilsson J, Frobert O, Hambraeus K, Varenhorst C, et al. Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI. J Am Coll Cardiol. 2014;64:16–24. https://doi.org/10.1016/j.jacc.2014.04.022.CrossRefPubMed

37.

Gomez-Lara J, Salvatella N, Gonzalo N, Hernández-Hernández F, Fernandez-Nofrerias E, Sánchez-Recalde A, et al. IVUS-guided treatment strategies for definite late and very late stent thrombosis. EuroIntervention. 2016;12:e1355–65. https://doi.org/10.4244/EIJY15M12_08.CrossRefPubMed

38.

Kosonen P, Vikman S, Jensen LO, Lassen JF, Harnek J, Olivecrona GK, et al. Intravascular ultrasound assessed incomplete stent apposition and stent fracture in stent thrombosis after bare metal versus drug-eluting stent treatment the Nordic intravascular ultrasound study (NIVUS). Int J Cardiol. 2013;168:1010–6. https://doi.org/10.1016/j.ijcard.2012.10.033.CrossRefPubMed

39.

Yamanaga K, Tsujita K, Shimomura H, Nakamura Y, Ogura Y, Onoue Y, et al. Serial intravascular ultrasound assessment of very late stent thrombosis after sirolimus-eluting stent placement. J Cardiol. 2014;64:279–84. https://doi.org/10.1016/j.jjcc.2014.02.008.CrossRefPubMed

40.

Souteyrand G, Amabile N, Mangin L, Chabin X, Meneveau N, Cayla G, Vanzetto G, Barnay P, Trouillet C, Rioufol G, Rangé G, Teiger E, Delaunay R, Dubreuil O, Lhermusier T, Mulliez A, Levesque S, Belle L, Caussin C, Motreff P, PESTO Investigators. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. Eur Heart J 2016;37:1208–1216. doi:https://doi.org/10.1093/eurheartj/ehv711.CrossRefPubMed

41.

Karalis I, Ahmed TAHN, Jukema JW. Late acquired stent malapposition: why, when and how to handle? Heart. 2012;98:1529–36. https://doi.org/10.1136/heartjnl-2011-301220.CrossRefPubMed

42.

Hassan AKM, Bergheanu SC, Stijnen T, van der Hoeven BL, Snoep JD, Plevier JWM, et al. Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J. 2010;31:1172–80. https://doi.org/10.1093/eurheartj/ehn553.CrossRefPubMed

43.

Mintz GS. Intravascular imaging of coronary calcification and its clinical implications. JACC Cardiovasc Imaging. 2015;8:461–71. https://doi.org/10.1016/J.JCMG.2015.02.003.CrossRefPubMed

44.

Rana O, Shah NC, Wilson S, Swallow R, O’Kane P, Levy T. The impact of routine and intravascular ultrasound-guided high-pressure postdilatation after drug-eluting stent deployment: the STent OPtimization (STOP) study. J Invasive Cardiol. 2014;26:640–6.PubMed

45.

Okabe T, Mintz GS, Buch AN, Roy P, Hong YJ, Smith KA, et al. Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am J Cardiol. 2007;100:615–20. https://doi.org/10.1016/J.AMJCARD.2007.03.072.CrossRefPubMed

46.

Liu X, Tsujita K, Maehara A, Mintz GS, Weisz G, Dangas GD, et al. Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation. JACC Cardiovasc Interv. 2009;2:997–1004. https://doi.org/10.1016/j.jcin.2009.07.012.CrossRefPubMed

47.

Cheneau E, Leborgne L, Mintz GS, Kotani J, Pichard AD, Satler LF, et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation. 2003;108:43–7. https://doi.org/10.1161/01.CIR.0000078636.71728.40.CrossRefPubMed

48.

Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, et al. The registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report-2012 heart transplant demographics transplant volumes 2012. doi:https://doi.org/10.1016/j.healun.2012.08.002.CrossRefPubMed

49.

Kobashigawa JA, Tobis JM, Starling RC, Tuzcu EM, Smith AL, Valantine HA, et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol. 2005;45:1532–7. https://doi.org/10.1016/J.JACC.2005.02.035.CrossRefPubMed

50.

Tuzcu EM, Kapadia SR, Sachar R, Ziada KM, Crowe TD, Feng J, et al. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol. 2005;45:1538–42. https://doi.org/10.1016/J.JACC.2004.12.076.CrossRefPubMed

51.

Okada K, Fearon WF, Luikart H, Kitahara H, Otagiri K, Tanaka S, et al. Attenuated-signal plaque progression predicts long-term mortality after heart transplantation. J Am Coll Cardiol. 2016;68:382–92. https://doi.org/10.1016/j.jacc.2016.05.028.CrossRefPubMedPubMedCentral

52.

Masetti M, Potena L, Nardozza M, Prestinenzi P, Taglieri N, Saia F, et al. Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. Am J Transplant. 2013;13:1217–26. https://doi.org/10.1111/ajt.12208.CrossRefPubMed

53.

Kobashigawa JA, Pauly DF, Starling RC, Eisen H, Ross H, Wang SS, et al. A2310 IVUS Substudy Investigators. Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients. Substudy fromthe everolimus versus mycophenolate mofetil randomized, multicenter trial. JACC Hear Fail. 2013;1:389–99. https://doi.org/10.1016/j.jchf.2013.07.002.CrossRef

Title: What Is the Clinical Utility of Intravascular Ultrasound?
Authors: Eisha Wali
Sandeep Nathan
Publication date: 01-11-2018
Publisher: Springer US
Published in: Current Cardiology Reports / Issue 11/2018
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-018-1062-z

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

What Is the Clinical Utility of Intravascular Ultrasound?

Abstract

Purpose of Review

Recent Findings

Summary

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 11/2018

Transcatheter Mitral Valve Therapy: Defining the Patient Who Will Benefit

Update on Devices for Diastolic Dysfunction: Options for a No Option Condition?

Pulmonary Embolism for the Cardiologist: Emphasis on Diagnosis

Atrial Cardiopathy and Stroke Prevention

Is There Still a Role for Digoxin in the Management of Atrial Fibrillation?

Dangers of Overly Aggressive Blood Pressure Control

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page